0001883850-22-000040.txt : 20220411 0001883850-22-000040.hdr.sgml : 20220411 20220411180129 ACCESSION NUMBER: 0001883850-22-000040 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220407 FILED AS OF DATE: 20220411 DATE AS OF CHANGE: 20220411 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Landry Robert E CENTRAL INDEX KEY: 0001585160 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 22820678 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2022-04-07 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001585160 Landry Robert E 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 EVP Finance CFO Common Stock 2022-04-07 4 M 0 1500 399.66 A 30244 D Common Stock 2022-04-07 4 F 0 1175 716.09 D 29069 D Common Stock 2022-04-08 4 S 0 16 724.33 D 29053 D Common Stock 2022-04-08 4 S 0 30 728.77 D 29023 D Common Stock 2022-04-08 4 S 0 16 729.67 D 29007 D Common Stock 2022-04-08 4 S 0 44 733.38 D 28963 D Common Stock 2022-04-08 4 S 0 43 735.12 D 28920 D Common Stock 2022-04-08 4 S 0 29 739.02 D 28891 D Common Stock 2022-04-08 4 S 0 28 740.98 D 28863 D Common Stock 2022-04-08 4 S 0 32 743.71 D 28831 D Common Stock 2022-04-08 4 S 0 56 744.52 D 28775 D Common Stock 2022-04-08 4 S 0 31 745.27 D 28744 D Common Stock 2022-04-08 4 M 0 6000 381.92 A 34744 D Common Stock 2022-04-08 4 F 0 4586 736.21 D 30158 D Common Stock 2022-04-08 4 M 0 2000 399.66 A 32158 D Common Stock 2022-04-08 4 F 0 1552 736.21 D 30606 D Common Stock 2022-04-11 4 S 0 74 729.76 D 30532 D Common Stock 2022-04-11 4 S 0 37 731.6 D 30495 D Common Stock 2022-04-11 4 S 0 22 732.56 D 30473 D Common Stock 2022-04-11 4 S 0 1226 733.52 D 29247 D Common Stock 2022-04-11 4 S 0 75 734.53 D 29172 D Common Stock 2022-04-11 4 S 0 149 735.36 D 29023 D Common Stock 2022-04-11 4 S 0 189 736.61 D 28834 D Common Stock 2022-04-11 4 S 0 22 737.89 D 28812 D Common Stock 2022-04-11 4 S 0 68 738.63 D 28744 D Common Stock 229 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 381.92 2022-04-08 4 M 0 6000 0.0 D 2026-12-16 Common Stock 6000 12800 D Non-Qualified Stock Option (right to buy) 399.66 2022-04-07 4 M 0 1500 0.0 D 2024-12-16 Common Stock 1500 2000 D Non-Qualified Stock Option (right to buy) 399.66 2022-04-08 4 M 0 2000 0.0 D 2024-12-16 Common Stock 2000 0 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 44 shares of Company stock on April 8, 2022 at prices ranging from $733.28 to $733.44. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 8, 2022 at each separate price. Represents volume-weighted average price of sales of 43 shares of Company stock on April 8, 2022 at prices ranging from $735.06 to $735.23. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 8, 2022 at each separate price. Represents volume-weighted average price of sales of 32 shares of Company stock on April 8, 2022 at prices ranging from $743.48 to $743.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 8, 2022 at each separate price. Represents volume-weighted average price of sales of 74 shares of Company stock on April 11, 2022 at prices ranging from $729.63 to $729.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 11, 2022 at each separate price. Represents volume-weighted average price of sales of 37 shares of Company stock on April 11, 2022 at prices ranging from $731.57 to $731.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 11, 2022 at each separate price. Represents volume-weighted average price of sales of 22 shares of Company stock on April 11, 2022 at prices ranging from $732.00 to $732.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 11, 2022 at each separate price. Represents volume-weighted average price of sales of 1,226 shares of Company stock on April 11, 2022 at prices ranging from $733.40 to $733.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 11, 2022 at each separate price. Represents volume-weighted average price of sales of 75 shares of Company stock on April 11, 2022 at prices ranging from $734.08 to $734.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 11, 2022 at each separate price. Represents volume-weighted average price of sales of 149 shares of Company stock on April 11, 2022 at prices ranging from $735.02 to $735.58. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 11, 2022 at each separate price. Represents volume-weighted average price of sales of 189 shares of Company stock on April 11, 2022 at prices ranging from $736.40 to $736.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 11, 2022 at each separate price. The stock option award vests in four equal annual installments, commencing one year after the date of grant. /s/**Robert E. Landry 2022-04-11